Statistics for Central Nervous System Outcomes of Lazertinib Versus Gefitinib in Egfr-Mutated Advanced Nsclc: a Laser301 Subset Analysis
Total visits
| views | |
|---|---|
| Central Nervous System Outcomes of Lazertinib Versus Gefitinib in Egfr-Mutated Advanced Nsclc: a Laser301 Subset Analysis | 3 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 3 |
| March 2026 | 0 |
File Visits
| views | |
|---|---|
| 5039.pdf | 3 |
Top country views
| views | |
|---|---|
| China | 2 |
| United States | 1 |